Acadia Healthcare Company, Inc. (ACHC) benefits from growing patient volumes, bed additions to existing facilities, joint ventures (JVs) and sound cash reserves.Zacks Rank & Price PerformanceAcadia Healthcare currently carries a Zacks Rank #3 (Hold).The stock has gained 10.6% in the past month against the industry’s 6.7% decline. The Zacks Medical sector and the S&P 500 composite have decreased 6.3% and 0.8%, respectively, in the same time frame.Image Source: Zacks Investment ResearchACHC’s Robust Growth Pr ...

FORT MYERS, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC). Accreditation is a process through which health care organizations demonstrate compliance with national standards. ACHC accreditation reflects an organization’s dedication to meeting standards that facilitate a high ...

文章核心观点 - 公司面临集体诉讼，指控其在财务结果和患者管理方面存在欺诈行为，导致股价大幅下跌 [1][3][4][5][6] 诉讼背景 - 公司是美国最大的营利性精神病医院连锁之一，诉讼指控公司在相关期间通过保险欺诈和非法扣留患者来虚报财务结果 [3] 关键事件 - 2024年9月1日，《纽约时报》发表文章揭露公司诱导患者入院并非法扣留，导致股价下跌4.5%，收盘价为$78.21 [4] - 2024年9月27日，公司披露收到美国检察官办公室和密苏里州西区联邦法院的传票，股价下跌16%，从$75.66跌至$63.28 [5] - 2024年10月18日，《纽约时报》再次报道退伍军人事务部正在调查公司涉嫌的保险欺诈，股价下跌12%，从$59.32跌至$52.03 [6] 投资者行动 - 投资者需在2024年12月16日前向法院申请成为案件主导，诉讼依据为《1934年证券交易法》第10(b)和20(a)条 [2] - 投资者可通过访问https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc提交信息，无需承担诉讼费用 [8][9] 法律团队 - 代表投资者的律师事务所Bleichmar Fonti & Auld LLP在证券集体诉讼和股东诉讼方面有丰富经验，2023年被评为前五大原告律师事务所，近期成功为特斯拉和Teva Pharmaceutical追回巨额赔偿 [10]

NEW YORK, Dec. 13, 2024 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the "Class Period"), of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.So what: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without paymen ...

RADNOR, Pa., Dec. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 30, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 16, 2024. CONTACT KESSLER TOPAZ MELTZER & C ...

NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

BOCA RATON, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Middle District of Tennessee against Acadia Healthcare Company, Inc. (“Acadia Healthcare,” “Acadia,” or the “Company”) (NASDAQ: ACHC) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) an ...

RADNOR, Pa., Dec. 11, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024.CONTACT KESSLER TOPAZ MELTZER & CHECK, ...

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”) of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without ...

文章核心观点 - 证券法律公司Bleichmar Fonti & Auld LLP对Acadia Healthcare Company, Inc.及其部分高级管理人员提起诉讼，指控其在财务结果上存在误导性陈述，涉及保险欺诈和非法拘禁患者的行为 [1][3] 诉讼背景 - 诉讼由Bleichmar Fonti & Auld LLP提起，指控Acadia Healthcare在相关期间内，其财务结果被误导性地归因于保险欺诈和非法拘禁患者，包括在非医疗必要的情况下 [3] - 投资者需在2024年12月16日前向法院申请成为案件的主要原告 [2] 关键事件 - 2024年9月1日，《纽约时报》发表文章揭露Acadia Healthcare诱导患者进入其设施并非法拘禁，导致Acadia股票价格下跌3.72美元，跌幅4.5%，收盘价为78.21美元 [4] - 2024年9月27日，Acadia披露收到美国纽约南区检察官办公室的信息请求、密苏里州西区联邦地方法院的陪审团传票，并预计将收到美国证券交易委员会的类似请求，导致股价下跌16%，从75.66美元跌至63.28美元 [5] - 2024年10月18日，《纽约时报》再次报道，美国退伍军人事务部正在调查Acadia是否通过延长患者住院时间进行保险欺诈，导致股价下跌12%，从59.32美元跌至52.03美元 [6] 投资者行动 - 投资者被鼓励提交信息以了解可能的法律选项，所有代理费用基于胜诉后收取，投资者无需承担任何法院费用或诉讼费用 [8] - 提交信息可通过网站https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc或联系Ross Shikowitz [9]